Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease
Chansik An, Youn Ah Choi, Dongil Choi, Yong Han Paik, Sang Hoon Ahn, Myeong-Jin Kim, Seung Woon Paik, Kwang-Hyub Han, Mi-Suk Park
Clin Mol Hepatol. 2015;21(3):279-286.   Published online 2015 Sep 30     DOI: https://doi.org/10.3350/cmh.2015.21.3.279
Citations to this article as recorded by Crossref logo
Impact of delayed time from diagnosis to treatment on the stage of hepatocellular carcinoma
Bing Quan, Wen-Tao Yan, Wan Yee Lau, Meng-Chao Wu, Tian Yang
Hepatobiliary & Pancreatic Diseases International.2019; 18(1): 100.     CrossRef
Magnetic Resonance Imaging Evaluation of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy: Long Term Imaging Follow-Up
Mishal Mendiratta-Lala, William Masch, Prasad R. Shankar, Holly E. Hartman, Matthew S. Davenport, Matthew J. Schipper, Chris Maurino, Kyle C. Cuneo, Theodore S. Lawrence, Dawn Owen
International Journal of Radiation Oncology*Biolog.2019; 103(1): 169.     CrossRef
Contrast-enhanced ultrasound of malignant liver lesions
Isabelle Durot, Stephanie R. Wilson, Jürgen K. Willmann
Abdominal Radiology.2018; 43(4): 819.     CrossRef
Extracellular contrast agent-enhanced MRI: 15-min delayed phase may improve the diagnostic performance for hepatocellular carcinoma in patients with chronic liver disease
Si Eun Lee, Chansik An, Shin Hye Hwang, Jin-Young Choi, Kyunghwa Han, Myeong-Jin Kim
European Radiology.2018; 28(4): 1551.     CrossRef
Rate of hepatocellular carcinoma surveillance remains low for a large, real-life cohort of patients with hepatitis C cirrhosis
Sally Ann Tran, An Le, Changqing Zhao, Joseph Hoang, Lee Ann Yasukawa, Susan Weber, Linda Henry, Mindie H Nguyen
BMJ Open Gastroenterology.2018; 5(1): e000192.     CrossRef
Spontaneous Slowing and Regressing of Tumor Growth in Childhood/Adolescent Papillary Thyroid Carcinomas Suggested by the Postoperative Thyroglobulin-Doubling Time
Toshihiko Kasahara, Akira Miyauchi, Takumi Kudo, Eijun Nishihara, Mitsuru Ito, Yasuhiro Ito, Minoru Kihara, Akihiro Miya
Journal of Thyroid Research.2018; 2018: 1.     CrossRef
Chronic Hepatitis B Infection
Lydia S. Y. Tang, Emily Covert, Eleanor Wilson, Shyam Kottilil
JAMA.2018; 319(17): 1802.     CrossRef
Screening for hepatocellular carcinoma: What is missing?
Neil J. Mehta, Aygul Dogan Celik, Marion G. Peters
Hepatology Communications.2017; 1(1): 18.     CrossRef
Imaging of hepatocellular carcinoma and image guided therapies - how we do it
Jonathon Willatt, Julie A. Ruma, Shadi F. Azar, Nara L. Dasika, F. Syed
Cancer Imaging.2017;[Epub]     CrossRef
Men with biopsy-confirmed hepatocellular adenoma have a high risk of progression to hepatocellular carcinoma: A nationwide population-based study
Lars Bossen, Henning Grønbaek, Peter Lykke Eriksen, Peter Jepsen
Liver International.2017; 37(7): 1042.     CrossRef
Adding to the evidence base: Effectiveness of hepatocellular carcinoma surveillance in clinical practice
Prashant Pandya, Fasiha Kanwal
Hepatology Communications.2017; 1(8): 723.     CrossRef
Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma
Jong Kwan Kim, Hyung-Don Kim, Mi-Jung Jun, Sung-Cheol Yun, Ju Hyun Shim, Han Chu Lee, Danbi Lee, Jihyun An, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee, Kang Mo Kim
Digestive Diseases and Sciences.2017; 62(10): 2923.     CrossRef
Liver Imaging Reporting and Data System: Review of Major Imaging Features
Irene Cruite, An Tang, Adrija Mamidipalli, Amol Shah, Cynthia Santillan, Claude B. Sirlin
Seminars in Roentgenology.2016; 51(4): 292.     CrossRef
Multiplication of Tumor Volume by Two Tumor Markers Is a Post-Resection Prognostic Predictor for Solitary Hepatocellular Carcinoma
Shin Hwang, Gi-Won Song, Young-Joo Lee, Ki-Hun Kim, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Dong-Hwan Jung, Gil-Chun Park, Sung-Gyu Lee
Journal of Gastrointestinal Surgery.2016; 20(11): 1807.     CrossRef